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Variation in Coronary Atherosclerosis Severity 
Related to a Distinct LDL (Low-Density 
Lipoprotein) Profile
Findings From a Familial Hypercholesterolemia Pig Model
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OBJECTIVE: In an adult porcine model of familial hypercholesterolemia (FH), coronary plaque development was characterized. 
To elucidate the underlying mechanisms of the observed inter-individual variation in disease severity, detailed lipoprotein 
profiles were determined.
APPROACH AND RESULTS: FH pigs (3 years old, homozygous LDLR R84C mutation) received an atherogenic diet for 12 months. 
Coronary atherosclerosis development was monitored using serial invasive imaging and histology. A pronounced difference 
was observed between mildly diseased pigs which exclusively developed early lesions (maximal plaque burden, 25% [23%–
34%]; n=5) and advanced-diseased pigs (n=5) which developed human-like, lumen intruding plaques (maximal plaque burden, 
69% [57%–77%]) with large necrotic cores, intraplaque hemorrhage, and calcifications. Advanced-diseased pigs and mildly 
diseased pigs displayed no differences in conventional risk factors. Additional plasma lipoprotein profiling by size-exclusion 
chromatography revealed 2 different LDL (low-density lipoprotein) subtypes: regular and larger LDL. Cholesterol, sphingosine-
1-phosphate, ceramide, and sphingomyelin levels were determined in these LDL-subfractions using standard laboratory 
techniques and high-pressure liquid chromatography mass-spectrometry analyses, respectively. At 3 months of diet, regular 
LDL of advanced-diseased pigs contained relatively more cholesterol (LDL-C; regular/larger LDL-C ratio 1.7 [1.3–1.9] versus 
0.8 [0.6–0.9]; P=0.008) than mildly diseased pigs, while larger LDL contained more sphingosine-1-phosphate, ceramides, and 
sphingomyelins. Larger and regular LDL was also found in plasma of 3 patients with homozygous FH with varying LDL-C ratios.
CONCLUSIONS: In our adult FH pig model, inter-individual differences in atherosclerotic disease severity were directly related to 
the distribution of cholesterol and sphingolipids over a distinct LDL profile with regular and larger LDL shortly after the diet 
start. A similar LDL profile was detected in patients with homozygous FH.
VISUAL OVERVIEW: An online visual overview is available for this article.
Key Words: animal model ◼ atherosclerosis ◼ biomarker ◼ coronary artery disease ◼ familial hypercholesterolemia ◼ hypercholesterolemia  
◼ sphingolipids
Coronary atherosclerotic plaque destabilization and rupture is one of the most important causes of acute coronary events and sudden death.1–3 Therefore, risk-assessment of atherosclerotic plaques before the occurrence of an acute coronary event is an important focus of coronary artery disease (CAD) research. Herein, in vivo 
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studies with serial imaging and histopathological analyses 
are essential to understand the mechanisms and causative 
factors of plaque growth and destabilization. Unfortunately, 
natural history studies in humans are limited by the long 
time-frame of disease development, by the small number of 
longitudinal (invasive) imaging time points, and by the very 
limited possibility to collect tissue. This urges the need for a 
preclinical animal model that presents with human-like CAD.
Because of their comparable coronary size, anatomy 
and diet, pigs are currently the animal model that most 
closely resembles the human disease pathophysiology, 
and that is most suitable for testing new imaging meth-
ods.4–6 Atherosclerosis development in pig models is often 
stimulated by an atherogenic diet7 or diabetes mellitus, or 
a combination of them.8–14 Some of the most successful 
porcine models for nonsurgical induced atherosclerosis 
carry mutations in genes that regulate the lipid metabolism, 
like in the LDLR15,16 or PCSK917 genes. These mutations 
are similar to those found in patients with familial hyper-
cholesterolemia (FH) and result in high plasma cholesterol 
levels.18 On an atherogenic diet, these FH pig models do 
develop (coronary) atherosclerotic disease, but, like in most 
other pig models, plaque progression is often modest, and 
does not reach human-like advanced disease stages with 
symptomatic plaques, especially in the coronary arteries.
Previous studies with atherosclerotic pig models assessed 
plaque development exclusively in young, growing animals. 
For humans, it is known that lipid profiles, blood pressure, 
arterial mechanics, and inflammatory status are very differ-
ent between adolescents and older people,19–21 while these 
are factors with a major impact on atherosclerotic disease 
development. These factors may thus also affect atheroscle-
rosis development in young pigs. Therefore, we refined a 
previously described and promising LDLR mutation mini-pig 
model15 by using adult animals from the start of the study. 
Furthermore, in contrast to earlier studies, we followed these 
animals for up to one year after the start of an atherogenic 
diet and monitored natural atherosclerotic plaque develop-
ment and composition in the coronary arteries using multiple 
invasive imaging techniques and histology. We provide a 
detailed analysis on plaque size, localization, and composition 
at 3 time points during the follow-up period on atherogenic 
diet as a road-map for future studies with this promising pig 
model. To unravel the underlying mechanisms contributing to 
the observed inter-individual variation in coronary atheroscle-
rotic plaque development that is observed similarly in patients 
with FH,22 we deployed a detailed plasma lipoprotein analysis.
MATERIALS AND METHODS
Please see Methods and the Major Resources Table in the 
online-only Data Supplement for further details on the histo-
logical staining methods and analysis, on the invasive image 
analysis, and on the lipoprotein profiling methods.
Pig Model, Plaque Imaging, and Histology
The animal study protocol was approved by the local animal 
ethics committee (DEC EMC3318 [109-14-10]), and the 
study was performed according to the National Institutes of 
Health guide for the Care and Use of Laboratory animals.23 
FH Bretonchelles Meishan minipigs homozygous for the LDLR 
R84C mutation (FBM, n=11, castrated male) as described 
before by Thim et al,15 were fed a normal laboratory diet (No. 
102243/60, Sanders Ouest, Etrelles, France) until the start of 
Nonstandard Abbreviations and Acronyms
AD advanced-diseased pig
Cer ceramide
DGUC density-gradient ultracentrifuge
FCA fibrous cap atheroma
FH   familial hypercholesterolemia
FPLC fast-protein liquid chromatography
HDL high-density lipoprotein
HDL-C HDL-cholesterol
IVUS intravascular ultrasound
LDL low-density lipoprotein
LDL-C LDL-cholesterol
MD mildly diseased pig
OCT optical coherence tomography
S1P sphingosine-1-phosphate
SM sphingomyelin
VLDL very-low-density lipoprotein
Highlights
• Adult familial hypercholesterolemia pigs on an ath-
erogenic diet developed coronary atherosclerosis 
with a clear distinction between mildly diseased pigs 
and advanced-diseased pigs.
• Plaques in the advanced-diseased pigs progressed 
to lumen intruding human-like plaques with vulnera-
ble characteristics including lipid-rich necrotic cores, 
calcifications, neovascularization, and intraplaque 
hemorrhage.
• The observed inter-individual differences in athero-
sclerotic disease severity in the pigs were directly 
related to the distribution of cholesterol and sphin-
golipids over a distinct LDL profile with regular and 
larger LDL observed shortly after the start of the 
diet.
• A similar LDL profile was detected in homozygous 
patients with FH, a finding that holds promise for 
early individual cardiovascular disease detection, but 
also as a treatment target.
See accompanying editorial on page 2203 
See cover image
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the study. Since female pigs of this breed develop considerably 
less coronary atherosclerosis (unpublished data by Drouet et 
al), and since the main aim of this study was to study devel-
opment of advanced atherosclerosis in this pig model, only 
castrated males were used. At the age of 34±3 months, an ath-
erogenic diet (10% lard and 0.75% cholesterol, The National 
Institute of Agronomic Research, France) was started. Plaque 
development in the coronary arteries was monitored by per-
forming invasive imaging of the left anterior descending, the 
left circumflex, and the right coronary artery using intravascular 
ultrasound (IVUS) and optical coherence tomography (OCT). 
The imaging protocol was performed at 3 time points (3 [T1], 9 
[T2], and 10 to 12 [T3] months on atherogenic diet) to assess 
(changes in) plaque size and composition.
The day before the imaging procedure, the pigs were fasted 
and were given an oral loading dose of 300 mg carbasalate 
calcium. On the day of the procedure, the animals were sedated 
with a mix of Xylazine (2.25 mg/kg, 20 mg/mL) and Zoletil 100 
(tiletamine/zolazepam; 6 mg/kg, 100 mg/mL) injected intra-
muscularly, anesthetized with sodium thiopental (4 mg/kg, 50 
mg/mL) administered via an ear vein, intubated and ventilated 
with oxygen (25%–30% v/v) and nitrogen (75%–80% v/v) to 
maintain blood gases within the physiological range. Anesthesia 
was maintained by isoflurane inhalation (1%–2.5% v/v).
Via a carotid sheath, arterial blood samples were collected, 
and 250 mg acetylsalicylic acid and 10 000 units of heparin 
were administered to prevent blood clotting. Heparin admin-
istration was repeated every hour in a dose of 5000 units. 
Subsequently, a guiding catheter (Mach 1, 8F, various types, 
Boston Scientific, Marlborough, MA) was advanced through the 
carotid sheath into the ostium of either one of the 3 main coro-
nary arteries under angiographic guidance to perform a series 
of imaging procedures. Before imaging, isosorbide mononitrate 
(0.04 mg/kg, 1 mg/mL) was administered via the guiding cath-
eter to induce epicardial coronary vasodilation. Starting position 
of all imaging catheters was registered by serial monoplane 
angiography under at least 2 angles. First, an OCT catheter 
(Dragonfly Optis Imaging Catheter, St Jude Medical, St Paul, 
MN) was advanced into the artery as distal as possible up to 
a maximal depth of 75 mm. A pullback of 75 mm (36 mm/s) 
was performed under a constant contrast (Visipaque 320, GE 
Healthcare, Buckinghamshire, United Kingdom) flush rate of 
4 mL/s (Medrad Injection System, Bayer HealthCare LLC, 
Whippany, NJ). Subsequently, an IVUS catheter (TVC Insight 
Coronary Imaging Catheter, InfraRedX, Burlington, MA) was 
positioned at the same anatomic location as the OCT catheter, 
and a pullback (0.5 mm/s) was performed. During the IVUS 
pullback, the heart rate was closely monitored and registered 
for later use in IVUS triggering.
During the imaging procedure at the first time point, one 
of the pigs died due to an acute cardiac tamponade and was 
excluded from the study. Furthermore, fast plaque development 
in 2 other pigs led to cardiovascular complications and subse-
quent early sacrifice shortly after T
2. Of these 2 latter pigs, the 
data of T1 and T2 were used for analysis. After the final imaging 
time point, the pigs were euthanized, and the coronary arteries 
were collected for histology.
Coronary tissue was sampled every 3 mm and was used for 
histological (Hematoxylin and Eosin, Resorcin-Fuchsin or Miller 
[collagen and elastin], Oil-red-O [lipids] and Martius, Scarlet 
and Blue [fibrin]) and immunohistochemical stainings (CD68 
[macrophages], CD31 [endothelial cells]). For the analysis, his-
tological slides taken every 3 mm were classified according to 
the revised AHA classification24 as no plaque, intimal thickening 
(IT), intimal xanthoma (IX), pathological intimal thickening (PIT), 
and fibrous cap atheroma (FCA). Quantification of the plaque 
components was performed by manual or semi-automatic 
delineation of the lumen, media, outer wall, and the respective 
plaque component on all histological slides using BioPix IQ 
software (BioPix AB, version 3.4.0).
Analysis of IVUS and OCT data was performed using QCU-
CMS software (version 4.69, Leiden University Medical Center, 
LKEB, Division of Image Processing/MEDIS medical imag-
ing systems BV, Leiden). ECG-gated IVUS images were ana-
lyzed approximately every 0.5 mm to assess lumen and outer 
wall dimensions and thus plaque size. For final analysis, data 
were averaged over 3 mm in longitudinal direction to reduce 
the influence of manual drawing errors and to reduce statisti-
cal dependence among the data points. The plaque size was 
also assessed by classifying the maximal intima-media thick-
ness per 3 mm-segment into 4 grades (<0.5 mm, 0.5–0.7 
mm, 0.7–1.0 mm, and >1.0 mm) according to the method of 
Chatzizisis et al.9 The percentage of the segments occupied by 
the respective grade was quantified per artery and averaged 
over all arteries.
OCT data were analyzed every millimeter (1 out of 5 frames) 
according to consensus standards25 as fibrous plaque, lipid-rich 
plaque or a FCA in pullbacks that showed at least one frame 
with visible plaque. Angles for individual plaque components 
were drawn manually.
Patient Data
EDTA plasma was collected from 3 homozygous LDLR muta-
tion FH patients who were treated at the Erasmus MC, the 
Netherlands. All patients provided written informed consent, 
and the collection of blood was approved by the Medical Ethical 
Committee of the Erasmus MC (MEC, 2012–309).
Lipoprotein Profiling
EDTA plasma and serum collected from the pigs at T1, T2, and 
T3 was used to perform lipoprotein profiling by density-gradient 
ultracentrifugation (DGUC) and size-exclusion chromatogra-
phy (fast-protein liquid chromatography [FPLC]). Cholesterol 
and triglyceride levels were determined in all gradient or elu-
tion fractions using standard laboratory methods. Sphingolipid 
(ceramides [Cer], sphingosine-1-phosphate [S1P], and sphin-
gomyelin [SM]) content of the total plasma and of the LDL 
fractions was measured using high-pressure liquid chroma-
tography mass-spectrometry analyses. For analysis, the total 
cholesterol (FPLC and DGUC), S1P (FPLC), ceramide (FPLC), 
and SM (FPLC) levels in the LDL fractions were assessed 
by calculating the area under the curve. Sphingolipid lev-
els were expressed relative to the total cholesterol levels in 
the respective lipoprotein pools. Also the Cer(d18:1/16:0)/
Cer(d18:1/24:0), Cer(d18:1/18:0)/Cer(d18:1/24:0), and 
Cer(d18:1/24:1)/Cer(d18:1/24:0) ratios were assessed 
within the LDL fractions.26
To identify different LDL subpopulations, the lipoproteins 
from pig plasma samples and from the patient with homozy-
gous FH plasma samples were first separated on density by 
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Figure 1. In vivo intravascular ultrasound (IVUS) and optical coherence tomography (OCT) analysis of coronary plaque development.  
IVUS analysis (A–E): A, Stacked histogram of the number of 3 mm segments (y axis) with a corresponding PB (%) at the last imaging time 
point (x axis) of the advanced-diseased pigs (ADs; black bars) and mildly diseased pigs (MDs; white bars) in the left anterior descending 
coronary artery (LAD), left circumflex coronary artery (LCX), and right coronary artery (RCA). B and C, Change of plaque area (PA; mm2; B) 
and lumen area (LA; C) between T1 and T3 (mean±SD). *P<0.05 compared with T1. #P<0.05 between MDs and ADs at the corresponding 
time point. D, Average percentage (±SD) of the number of 3 mm segments per artery that displayed one of the maximal intima-media thickness 
(IMT) grades at the last imaging time point. *P<0.05 compared with FRs. E, Example IVUS images of plaque growth between T1 and T3 at one 
location in an AD pig. Vessel wall (green) and lumen border (red) are indicated. OCT analysis (F–H): F, Average percentage of a fibrous, lipid-
rich (*) or fibrous cap atheroma (FCA; arrowhead points out lipid-pool with overlying fibrous cap) of all plaque positive frames for T1 to T3. The 
total number of plaque positive frames and arteries is depicted under the figure. #Note that at T3, data of 2 highly atherosclerotic AD pigs are 
missing due to early sacrifice after T2. G, The average angle of fibrous plaque, lipid-rich plaque, or lipid-pool per frame at T1 to T3. H, Median 
(range) cap thickness values derived from the frames presenting with a lipid-pool (ie, FCA). The minimal (Min.) and average thickness, and the 
number of fibrous caps are displayed.
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DGUC. From these density-gradients, the LDL fractions were 
isolated and subsequently separated on size by FPLC.
Statistics
IBM SPSS Statistics (version 21.0) software was used for 
statistical analysis. Non-normal distributed data are presented 
as median (range), and statistical difference was determined 
with the Mann-Whitney U test. Normally, distributed data are 
shown as mean±SD, and significance was determined using an 
unpaired Student t test, a repeated-measures ANOVA with post 
hoc testing (Bonferroni) or a paired Student t test. Difference 
in the frequency distribution of different plaque categories was 
tested using a χ2 test or a Fisher exact test. Absolute values 
subtracted from imaging and histological data were averaged 
per artery. For categorical multiple group comparison, z-scores 
>1.96 were regarded significant. For all other tests, P<0.05 
was regarded to indicate statistical significance.
RESULTS
General Model Characteristics
The weight of the pigs remained constant during the 
follow-up period at 86 kg (60–104 kg). After 3 months 
of atherogenic diet, a significant increase in total cho-
lesterol (from 1.9 mmol/L [1.8–2.2 mmol/L] to 10.4 
mmol/L [8.9–22.3 mmol/L]), LDL-C (LDL-cholesterol; 
from 1.5 mmol/L [1.4–1.8 mmol/L] to 8.8 mmol/L 
[6.7–23.3 mmol/L]) and HDL-C (HDL-cholesterol) lev-
els (from 0.3 mmol/L [0.2–0.3 mmol/L] to 2.9 mmol/L 
[2.1–4.9 mmol/L]) was observed compared the levels 
before atherogenic diet (P<0.05).
Advanced and Mildly Diseased Pigs: General 
Characteristics and In Vivo IVUS Measurements 
of Plaque Size and Plaque Growth
Five of the 10 pigs displayed development of large, 
lumen intruding plaques in the coronary arteries (maximal 
plaque burden 69% [57%–77%]; advanced-diseased 
pigs [ADs]) while the other 5 pigs showed limited plaque 
development (maximal plaque burden 25% [23%–34%]; 
mildly diseased pigs [MDs]; Figure 1A). Although the 
animals were run in 2 subsequent groups, the distribu-
tion of the AD/MD animals over both groups appeared 
random (Group 1: 2/6; Group 2: 3/5 [ADs/total number 
of animals]), ruling out the effect of factors like housing, 
diet, seasonal period or birth-year. Since the difference in 
plaque development between both groups was so pro-
nounced, all subsequent results are presented separately 
for the MDs and the ADs.
In the ADs, plaque area was markedly larger, and 
lumen area was smaller compared with the MDs 
(P<0.05; Figure 1B and 1C). The ADs demonstrated 
significant increase in plaque area (Figure 1B) and 
decrease in lumen area (Figure 1C) at T2 and T3 com-
pared with T1 (P<0.05). In the MDs, plaque growth 
(Figure 1B) was limited but still significant (P<0.05), 
while the lumen area (Figure 1C) showed a slight 
increase from T1 to T2 (P<0.05) and a decrease at T3 
(P<0.05).
At the last time point, on average 21% of the analyzed 
segments of the ADs was occupied by plaques with a 
maximal intima-media thickness >1.0 mm while in the 
MDs none of the segments demonstrated plaques with 
this intima-media thickness grade (Figure 1D).
Plaque Classification by OCT
The percentage of OCT frames that presented with 
plaque increased over time in both the MD and AD pigs 
(Figure 1F). The large majority of the OCT-detected 
plaques presented as lipid-rich, and this distribution did 
not change over time (Figure 1F). OCT-observed FCAs 
were rare. In ADs, OCT-FCA occurrence increased 
between T1 and T2 from 4.4% (7 frames) to 7.4% (35 
frames) of the total number of frames with plaque 
(P=0.001) and tended to decrease again at T3 to 3.8% 
(11 frames; P=0.07; Figure 1F). This latter observation 
is explained by the loss of 2/5 AD pigs before T3 which 
demonstrated the majority of OCT-FCAs (57%) at T2. In 
the MDs, OCT-FCAs were only observed at T3 in 2.0% 
(3 frames) of the total number of frames with plaque. In 
a more detailed analysis, the ADs displayed an increase 
in the average total plaque angle between T1 and T2 
which could mainly be attributed to the increase in both 
fibrous and lipid-rich angles (P<0.05; Figure 1G). Fur-
thermore, there was a small, but nonsignificant increase 
in the lipid-pool angle. Between T2 and T3, both the aver-
age plaque angle and the composition remained con-
stant in the ADs which can again be explained by the 
loss of 2 AD pigs with the most advanced plaques at T2. 
The MDs displayed a small, but nonsignificant increase 
in average plaque angle and no significant changes in 
plaque composition were observed (Figure 1G). Cap 
thickness was determined in OCT-FCAs (Figure 1H) 
and in the ADs, respectively 2 (T1), 3 (T2), and 1 (T3) 
frames presented with a thin-fibrous cap (<65 µm). In 
the MDs, one frame with a thin-FCA was observed and 
only at T3.
Histological Characterization of the Coronary 
Atherosclerotic Plaques
Plaque Classification and Localization
In total, 580 coronary 3 mm segments were analyzed 
by histology: 297 segments from ADs and 283 seg-
ments from MDs, with on average 19±6 segments per 
artery. In the ADs, the presence of a healthy vessel wall 
or a vessel wall with IT was rare, while IX, PIT, and FCA 
were each present in approximately one-third of all ana-
lyzed segments (Figure 2A). For the MDs, IX was the 
most frequently observed plaque type, covering 73.5% 
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Figure 2. Histological quantification of coronary plaque classification and components.  
A, Quantification of the frequency of occurrence of the different plaque types. Data are presented as a percentage of the total number of 
segments, separately for the mildly diseased pigs (MDs; 283 3 mm segments) and advanced-diseased pigs (AD) pigs (297 3 mm-segments). 
*z-score >1.96 compared with ADs. Bottom of the figure: example images of the respective plaque types: no plaque and intimal thickening: 
HE-staining; other plaque types: Oil-red-O staining (red=lipids and purple=calcifications). B, Mean (±SD) percentage of 3 mm segments per 
artery that contained the respective plaque component in ADs (black bars) and MDs (white bars). *P<0.05. C–F, Histological examples of 
the plaque components quantified in the bar graph. C, Neovascularisation (*, CD31-staining: brown), (D) magnification of (C). E, Intraplaque 
hemorrhage (†, HE-staining). F, Lipids (Oil-red-O staining: red), microcalcifications (arrowhead), and macrocalcifications (arrows). G, Mean 
(±SD) area percentage per artery of the respective plaque component in ADs (black bars) and MDs (white bars) in segments positive for 
that plaque component. *P<0.05 compared with ADs. H–K, Example images of: (H) lipids (Oil-red-O staining; red); (I) macrophages (CD68 
staining: brown); (J) collagen (Miller staining: purple). The Miller staining was used to delineate the necrotic core (indicated in yellow in [K]).
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of the segments. The frequency of the various plaque 
classes differed significantly between the ADs and MDs 
(Χ2=211.0, P<0.0001; Figure 2A).
The plaque area of each respective plaque type did 
not differ between AD and MD pigs (Table 1), while the 
intima/media ratio for segments with PIT was signifi-
cantly higher in the AD than the MD pigs.
In the ADs, the anatomic distribution of the various 
plaque types differed significantly over the coronary 
arteries with a higher frequency of FCAs in the proxi-
mal part of the arteries compared with the distal part 
(χ2=39.6, P<0.0001). In contrast, the plaque type distri-
bution in the MDs was more homogenous (Figure IA in 
the online-only Data Supplement). Mainly for the MDs, 
the presence of a side branch coincided with a trend 
towards a more advanced plaque type (Figure IB in the 
online-only Data Supplement). In comparison with the 
left anterior descending and right coronary artery, the 
left circumflex presented with more early-stage plaques 
which were most apparent in the MDs (Figure IC in the 
online-only Data Supplement).
Quantification of Plaque Components
Neovascularization, intraplaque hemorrhage, and macro-
calcifications were frequently observed in the ADs and 
were rare in the MDs (P<0.05), while micro-calcifications 
were equally present (Figure 2B through 2F). Furthermore, 
coronary segments obtained from the ADs contained a 
significantly larger area percentage of lipids and macro-
phages compared with the MDs (Figure 2G through 2I) 
when the component was present. In necrotic core posi-
tive segments, the necrotic core area percentage did not 
differ (Figure 2G, 2J, and 2K), but necrotic cores were 
much more frequently present in plaques from ADs (102 
segments, 34%) compared with MDs (3 segments, 1%).
Lipoprotein Profiling of the Advanced and Mildly 
Diseased Pigs
The ADs and MDs carried the same LDLR mutation 
were fed the same amount of atherogenic diet and dis-
played no differences in conventional risk factors such as 
weight, total cholesterol levels, leucocyte count (inflam-
mation), LCL-C, HDL-C, and the ratio of LDL-C/HDL-C 
(Table I in the online-only Data Supplement). To increase 
understanding of the large differences in coronary plaque 
development between the MD and AD pigs, detailed lipo-
protein profiling was performed.
Detection of Regular LDL and Larger LDL at T1
Separation of the plasma lipoproteins by density (DGUC) 
showed high LDL-C levels and relatively low HDL-C 
and VLDL-C (very-low density lipoprotein cholesterol) 
levels (Figure II in the online-only Data Supplement) in 
all pigs. AD and MD pigs demonstrated no significant 
differences in total LDL-C in DGUC at T1 (area under 
the curve, 7.1 [4.5–18.1] versus 7.1 [5.1–10.3]; Figure II 
in the online-only Data Supplement). Separation of the 
plasma lipoproteins by size (FPLC), however, revealed a 
marked difference in distribution of cholesterol over the 
lipoproteins between AD and MD pigs which was most 
pronounced in the fractions expected to contain LDL-C 
and VLDL-C (Figure 3A and Figure II in the online-only 
Data Supplement). While cholesterol was detected at 
both the LDL and VLDL location in the FPLC fractions, 
the lipoproteins at the VLDL location did not contain tri-
glycerides (Figure II in the online-only Data Supplement). 
Since VLDL is characterized by high levels of triglycer-
ides (as for example observed in human pool plasma, 
Figure II in the online-only Data Supplement), the almost 
absent triglycerides at the VLDL location suggest that 
the observed larger lipoprotein subpopulation is highly 
unlikely to be VLDL. In line with this, the DGUC profiles 
showed hardly any cholesterol in the fractions in the 
VLDL-density range (Figure II in the online-only Data 
Supplement). To further elucidate the origin of the larger-
sized lipoproteins, we isolated the DGUC LDL fractions 
and subsequently separated these fractions on size by 
FPLC. This analysis excluded the presence of VLDL and 
revealed the presence of LDL within the size-range of 
regular LDL, but also of LDL within the size-range of 
VLDL (Figure 3B). Based on these data, we will from 
now on call the specific lipoprotein subclass with the 
density of LDL, but the size of VLDL: larger LDL.
In the AD pigs, the regular/larger LDL-C ratio was 
significantly and consistently higher than in MD pigs at 
T1 (Table 2).
Sphingolipid Content of Regular and Larger  
LDL at T1
Next, the sphingolipid content of the 2 LDL subclasses 
was determined and expressed relative to the cholesterol 
concentration. In the ADs, the Cer(d18:1/18:0) content 
of the larger LDL was significantly higher than in MDs 
(Table 3). Furthermore, the regular/larger LDL ratios 
of S1P(d18:1), Cer(d18:1/16:0), and Cer(d18:1/18:0) 
were significantly lower in the ADs than in the MDs. 
Cer(d18:1/14:0) showed a similar trend (Table 3). 
These results indicate relatively higher S1P and long-
chain ceramide levels in larger LDL and lower lev-
els in regular LDL of the AD pigs compared with the 
MD pigs. Moreover, compared with the MDs, a lower 
ratio of Cer(d18:1/16:0)/Cer(d18:1/24:0; P=0.10) 
and Cer(d18:1/18:0)/Cer(d18:1/24:0; P=0.03) was 
observed in regular over larger LDL in ADs (Table II in 
the online-only Data Supplement). This indicated that in 
the ADs, larger LDL contained relatively more long-chain 
ceramides (Cer[d18:1/16:0] and Cer[d18:1/18:0]) and 
less very long-chain ceramides (Cer[d18:1/24:0]) com-
pared with regular LDL, whereas in MDs there were 
relatively less long-chain ceramides in relation to very-
long-chain ceramides. No differences were found in the 
Cer(d18:1/24:1)/Cer(d18:1/24:0) ratio in regular over 
D
ow
nloaded from
 http://ahajournals.org by on December 11, 2019
TRANSLATIONAL SCIENCES - AL
Hoogendoorn et al Atherosclerotic Pig Model: LDL and Disease Severity
Arterioscler Thromb Vasc Biol. 2019;39:2338–2352. DOI: 10.1161/ATVBAHA.119.313246 November 2019  2345
larger LDL (Table II in the online-only Data Supplement) 
between ADs and MDs.
With regard to the SMs, the SM(d18:1/16:0) and 
SM(d18:1/18:0) content was higher in larger LDL 
of ADs than of MDs (Table 4). A similar trend was 
observed for SM(18:1/20:0; P=0.06). Following the 
first 2 observations, also the regular/larger LDL ratios of 
SM(d18:1/16:0) and SM(d18:1/18:0) were significantly 
lower in the AD pigs than in the MD pigs. This same sig-
nificant difference was observed for the SM total regu-
lar/larger ratio (Table 4).
Cholesterol and Sphingolipid Content of Regular 
and Larger LDL at T2 and T3
As for the T1 plasma samples, we determined the choles-
terol and sphingolipid content of the 2 LDL subtypes in 
the plasma samples taken at T2 and T3. In contrast to the 
findings of T1, no differences were observed in the distri-
bution of cholesterol over regular and larger LDL between 
both groups of pigs at T2 and T3 (Table III in the online-only 
Data Supplement). For the sphingolipid content, no differ-
ences were found in the distribution of both ceramides 
and SMs over regular and larger LDL (Tables IV through 
Figure 3. Distinct lipoprotein profile with larger and regular LDL (low-density lipoprotein) associated with coronary 
atherosclerosis disease severity at T1.  
A, Representative fast-protein liquid chromatography (FPLC) profiles of one advanced-diseased pig (AD) and one mildly diseased pig. Both 
the cholesterol levels (black line) and the triglyceride levels (gray line) are indicated. Larger LDL has the same size as VLDL (very-low–density 
lipoproteins). B, Sequential separation of lipoproteins using density-gradient ultracentrifuge (DGUC) and FPLC (graph of one example AD pig). 
Lipoproteins were separated on density using DGUC. Subsequently, the pooled LDL fractions were subjected to FPLC revealing the presence 
of regular LDL and larger LDL. HDL indicates high-density lipoprotein.
Table 1. Plaque Area and Intima-Media Ratio for Every Plaque Type as Determined by Histology
Advanced-Diseased Pigs Mildly Diseased Pigs
IT IX PIT FCA IT IX PIT FCA
PA, mm2 0.90±1.12 0.92±0.60 2.09±0.90 4.23±1.38 0.69±0.55 0.75±0.34 1.78±0.65 3.38±2.25†
IMR 0.63±0.68 0.69±0.35 1.78±0.48 2.56±0.70 0.35±0.23 0.54±0.36 1.06±0.38* 1.48±0.74†
FCA indicates fibrous cap atheroma; IMR, intima/media ratio; IT, intimal thickening; IX, intimal xanthoma; PA, plaque area; and PIT, pathological intimal thickening.
*P<0.05 compared with the same plaque type of the advanced-diseased pigs.
†FCA in mildly diseased pigs: n=3, no statistics performed on this category.
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IX in the online-only Data Supplement). The total plasma 
levels of Cer(18:1/18:0) and Cer(18:1/24:0) were, how-
ever, higher in the AD than in the MD animals at T2 (Table 
IV in the online-only Data Supplement).
LDL Profile in Patients With Homozygous FH
Clinical characteristics of the 3 homozygous patients with 
FH, all carrying LDLR mutations, are described in Table X 
in the online-only Data Supplement. Isolation of LDL by 
DGUC and subsequent separation of the isolated LDL 
fractions by FPLC revealed the presence of regular and 
larger LDL in the plasma of all 3 patients with homozy-
gous FH. The LDL profiles of patient 2 and 3 were similar 
to the T1 LDL profiles of the ADs with higher regular LDL-C 
levels compared with larger LDL-C levels while patient 1 
displayed an LDL-C profile similar to MDs (Figure 4).
DISCUSSION
Our main findings were that: (1) on an atherogenic diet, 
plaques in all homozygous FH pigs progressed signifi-
cantly, but we could distinguish MDs and ADs, despite the 
presence of the same homozygous LDLR R84C mutation 
and similar cholesterol, LDL-C, HDL-C, and inflammatory 
levels; (2) the plaques of the MDs progressed to a stage 
of IX while in the ADs, large, advanced plaques with vul-
nerable characteristics including lipid-rich necrotic cores, 
calcifications, neovascularization, and intraplaque hemor-
rhage were frequently observed; (3) separation of plasma 
lipoproteins based on size revealed a distinct LDL profile 
which differed significantly between ADs and MDs at T1. 
This LDL profile contained both regular LDL and lipo-
proteins with the density of LDL and the size of VLDL, 
that is, larger LDL; (4) the distribution of cholesterol and 
sphingolipids over regular and larger LDL shortly after 
the start of the atherogenic diet could significantly and 
consistently be linked to the severity of subsequent coro-
nary atherosclerosis development; (5) the distinct LDL 
profile with larger and regular LDL was also observed in 
plasma of homozygous patients with FH.
Coronary Atherosclerosis Development: 
Comparison With Other Pig Models
Although the MD pigs in our study did develop early 
plaques with a growth rate consistent to humans (on 
average 0.05 mm2/month versus 0.02 mm2/month27), 
pigs that develop more advanced, unstable plaques are 
most useful for cardiovascular studies. Therefore, we 
compared the results from the AD pigs with data from 
previously published studies on pig models of nonsur-
gically induced coronary atherosclerosis development 
(Table XI in the online-only Data Supplement).
Coronary Plaque Size
In comparison with all other porcine models of diet- or 
genetically induced hypercholesterolemia with or with-
out diabetes mellitus, our AD pigs present with one of 
the largest histological plaque sizes (Table XI in the 
online-only Data Supplement). Only the atherogenic 
diet-diabetes mellitus pig model described by Patel et 
al12 presented with on average larger plaque areas (5.0 
versus 8.2 mm2). Differences in tissue processing and 
the lack of perfusion fixation in many studies, including 
ours, however, hampers a direct comparison, especially 
with the results of 3 studies which do use this tissue 
processing technique.15,16,28
Although the lack of perfusion fixation of the his-
tological samples could lead to overestimation of the 
plaque size, invasive imaging confirmed the presence of 
large plaques in our animals where 21% of the artery 
was occupied by plaques with a maximum intima-media 
thickness >1.0 mm. Furthermore, IVUS-derived plaque 
burden is a measure that is often applied in the clinic 
to quantify disease burden, but is unfortunately rarely 
reported by other porcine model studies. Badin et al29 
and Tharp et al30 observed average plaque burdens of 
38% and 50%, respectively. We demonstrated a maximal 
plaque burden of 77% in the ADs, indicating the pres-
ence of lumen intruding, clinically relevant plaques.31
Coronary Plaque Composition
Monitoring changes in plaque composition in animal mod-
els by serial invasive imaging is vital to assess the devel-
opment stage, plaque stability, and similarity to human 
plaques. Our OCT imaging data showed a clear increase 
of coronary atherosclerosis over time. The large majority 
of the plaques presented as lipid-rich already from the 
first time point, whereas lipid-pools, that is, FCAs, were 
rare, even at the last imaging time point. This observa-
tion is in large contrast to our histological data and might 
be the result of the main drawback of OCT: the inability 
to image beyond lipid-rich tissue.25 According to our his-
tological analysis, one-third of the plaques in the ADs 
presented as FCAs with lipid-rich necrotic cores. The 
majority of these FCAs were thick-cap FCAs and lipid-
rich tissue, present between the lumen and the lipid-pool, 
could shield the lipid-pool from detection by OCT, leading 
to an underestimation of FCA presence by OCT.
The histologically detected advanced plaque types 
PIT and FCAs were observed more frequently in the 
ADs from our study compared with many other mod-
els described in literature,9,10,13,14,17,28,32,33 except for the 
Table 2. Cholesterol Content of Regular and Larger LDL
Advanced- 
Diseased Pigs
Mildly  
Diseased Pigs P Value
Cholesterol regular LDL 6.3 (6.1–17.7) 7.3 (3.6–7.7) 1
Cholesterol larger LDL 1.9 (1.3–5.3) 5.0 (2.3–7.3) 0.22
Ratio cholesterol regular/ 
larger LDL
3.3 (2.5–4.7) 1.5 (1.1–1.8) 0.008*
Data presented as median (range) of the area under the curve. LDL indicates 
low-density lipoprotein.
*Significant values.
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atherogenic diet-diabetes mellitus model by Patel et al12 
(Table XI in the online-only Data Supplement), confirming 
that the advanced disease stage observed in our model 
is very rare.
Besides a generally advanced plaque type, ADs dis-
played important features of unstable plaques.24 Several 
of the previously studied porcine models also present 
with plaques that display necrotic cores, calcifications, 
and neovascularisation,8–10,14,17,34 although quantification 
is often not reported. While some articles also report the 
occurrence of intraplaque hemorrhage,8,15,17,34 the AD 
pigs in this study present widespread intraplaque hemor-
rhage, known to be an important indicator of fast plaque 
growth and destabilization.35
While the MD pigs displayed more diffuse disease 
development, AD pigs developed the largest and most 
advanced plaques mainly in the proximal coronary regions. 
This latter observation very well matches the coronary 
atherosclerosis growth patterns observed in humans.36
Taken together, the AD pigs of the adult FBM minipig 
model from this study develop some of the most advanced 
plaques so far described in literature, and this model is not 
complicated by the introduction of extra risk factors like 
diabetes mellitus.12 The development of the large plaques 
with unstable, human-like features as observed in the AD 
pigs is likely associated with the advanced age of the ani-
mals. Unlike almost all previous studies (Table XI in the 
online-only Data Supplement), we used adult pigs instead 
of juveniles for our experiments. As mentioned in the intro-
duction, the adult age greatly improves the resemblance 
to human disease pathophysiology, and aging is known to 
enhance atherosclerosis development both in pigs29 and 
Cer(d18:1/24:1) total 
plasma (×10−5)
19.9 (11.3–24.9) 16.5 (12.8–32.3) 1
Cer(d18:1/24:1) regular 
LDL (×10−5)
10.8 (6.3–12.7) 7.6 (6.7–13.4) 0.69
Cer(d18:1/24:1) larger 
LDL (×10−5)
14.9 (8.4–16.3) 12.6 (8.5–14.7) 0.22
Cer(d18:1/24:1) regular/
larger LDL ratio
0.7 (0.7–0.8) 0.7 (0.6–1.0) 1
Cer Total total plasma 
(×10−5)
80.4 (41.5–120.7) 66.8 (52.7–128.8) 0.84
Cer Total regular LDL 
(×10−5)
54.2 (27.6–58.8) 38.7 (29.9–62.7) 0.55
Cer Total larger LDL 
(×10−5)
77.6 (43.3–85.3) 58.1 (38.6–65.0) 0.10
Cer Total regular/larger 
LDL ratio
0.7 (0.6–0.8) 0.8 (0.7–1.0) 0.22
All sphingolipid data were expressed relative to the cholesterol concentration 
in total plasma or the respective LDL peak. Data are presented as median (range) 
of the area under the curve. LDL indicates low-density lipoprotein.
*Significant values.
†Data of 1 pig are missing.
Table 3. S1P and Ceramide Content of Regular and Larger LDL
Advanced- 
Diseased Pigs
Mildly  
Diseased Pigs P Value
S1P(d18:1) total plasma 
(×10−5)
12.4 (3.7–16.7)* 14.4 (7.7–17.4) 0.84
S1P(d18:1) regular LDL 
(×10−5)
2.7 (1.7–13.0)* 4.7 (1.3–6.4) 0.42
S1P(d18:1) larger LDL 
(×10−5)
4.7 (2.9–17.2)* 3.6 (1.4–7.9) 0.56
S1P(d18:1) regular/larger 
LDL
0.6 (0.5–0.8)* 0.9 (0.8–1.3) 0.016†
Cer(d18:1/14:0) total 
plasma (×10−5)
0.9 (0.4–1.2) 0.7 (0.4–1.1) 1
Cer(d18:1/14:0) regular 
LDL (×10−5)
0.6 (0.4–1.0) 0.6 (0.3–1.1) 1
Cer(d18:1/14:0) larger 
LDL (×10−5)
1.1 (0.9–1.6) 0.6 (0.4–1.5) 0.42
Cer(d18:1/14:0) regular/
larger LDL ratio
0.6 (0.4–0.8) 0.8 (0.7–0.9) 0.06
Cer(d18:1/16:0) total 
plasma (×10−5)
7.3 (3.4–11.1) 6.9 (3.7–9.3) 0.69
Cer(d18:1/16:0) regular 
LDL (×10−5)
13.3 (4.7–14.7)) 9.2 (5.2–12.6) 0.55
Cer(d18:1/16:0) larger 
LDL (×10−5)
19.7 (7.9–21.6) 11.9 (6.3–13.0) 0.31
Cer(d18:1/16:0) regular/
larger LDL ratio
0.7 (0.6–0.7) 0.8 (0.8–1.1) 0.008†
Cer(d18:1/18:0) total 
plasma (×10−5)
2.4 (1.2–3.8) 1.7 (1.4–2.6) 0.55
Cer(d18:1/18:0) regular 
LDL (x10−5)
5.3 (2.2–7.8) 3.0 (2.6–6.7) 0.69
Cer(d18:1/18:0) larger 
LDL (×10−5)
7.9 (4.0–11.8) 3.8 (2.8–4.4) 0.032†
Cer(d18:1/18:0) regular/
larger LDL ratio
0.6 (0.5–0.7) 1.0 (0.7–1.5) 0.008†
Cer(d18:1/20:0) total 
plasma (×10−5)
8.9 (3.6–14.8) 7.2 (6.5–14.7) 0.84
Cer(d18:1/20:0) regular 
LDL (×10−5)
5.0 (2.0–5.9) 3.5 (2.7–6.6) 0.55
Cer(d18:1/20:0) larger 
LDL (×10−5)
6.1 (2.8–8.9) 5.3 (3.7–7.0) 0.55
Cer(d18:1/20:0) regular/
larger LDL ratio
0.8 (0.7–0.9) 0.7 (0.6–0.9) 0.69
Cer(d18:1/22:0) total 
plasma (×10−5)
20.9 (9.7–38.7) 18.3 (13.8–36.4) 1
Cer(d18:1/22:0) regular 
LDL (×10−5)
8.2 (3.8–11.9) 6.0 (4.8–12.1) 0.55
Cer(d18:1/22:0) larger 
LDL (×10−5)
13.5 (5.9–17.2) 9.6 (6.5–13.9) 0.55
Cer(d18:1/22:0) regular/
larger LDL ratio
0.7 (0.6–0.9) 0.7 (0.6–0.9) 1
Cer(d18:1/24:0) total 
plasma (×10−5)
20.8 (11.8–35.3) 17.1 (12.8–32.8) 1
Cer(d18:1/24:0) regular 
LDL (×10−5)
11.1 (7.7–11.9) 8.3 (6.1–13.2) 0.31
Cer(d18:1/24:0) larger 
LDL (×10−5)
16.3 (12.4–18.8) 13.5 (9.8–15.9) 0.15
Cer(d18:1/24:0) regular/
larger LDL ratio
0.62 (0.5–0.8) 0.62 (0.6–0.9) 0.69
Table 3. Continued
Advanced- 
Diseased Pigs
Mildly  
Diseased Pigs P Value
(Continued )
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in humans.19–21 The extensive characterization of coro-
nary atherosclerosis development in this model forms a 
road-map for future pathophysiological or imaging stud-
ies with this highly relevant model. Selection of the ADs 
on forehand by using the described lipoprotein profiling 
would further accommodate this. Future studies will have 
to provide more information on sex-dependent differences 
and a possible genetic basis and heredity of the observed 
inter-individual differences in disease development.
The Distribution of Cholesterol and 
Sphingolipids Over LDL Subclasses Is Directly 
Linked to the Severity of Subsequent Coronary 
Atherosclerosis Development
Although inter-individual variation in CAD development 
has been previously observed in patients with FH22 as 
well as in other animal models of FH, such a pronounced 
difference in disease development as observed in our 
pig model has, to the best of our knowledge, not been 
reported before. Conventional risk factors such as total 
cholesterol, LDL-C, and inflammatory markers could not 
distinguish AD from MD pigs. Detailed lipoprotein analy-
sis, performed to elucidate possible underlying mecha-
nisms, however, revealed an LDL profile with regular and 
larger LDL in FH pigs shortly after the start of the ath-
erogenic diet that was distinctly different between MD 
and AD pigs.
LDL is an established and important initiator and pro-
motor of atherosclerosis and remains the primary target of 
prevention of CAD.37 Not only the concentration of circu-
lating LDL determines the risk of CAD, also differences in 
size, density, and composition can influence its atheroge-
nicity.38 For example, predominance of small-dense LDL 
has been strongly correlated with an increased risk of 
CAD.39 Besides smaller LDL, in previous studies, also the 
shift towards larger, triglyceride-rich IDL (intermediate-
density lipoproteins)-sized lipoproteins has been linked 
to the occurrence of myocardial infarction.40 In our cur-
rent study, the observed LDL-C profile with regular and 
larger LDL distinguished AD from MD pigs in all cases. 
SM Total total plasma 
(×10−3)
46.5 (36.5–56.4) 47.2 (36.1–68.3) 0.84
SM Total regular LDL 
(×10−3)
50.7 (47.1–61.1) 47.8 (38.1–52.4) 0.69
SM Total larger LDL 
(×10−3)
72.4 (65.2–80.7) 54.9 (44.4–69.7) 0.10
SM Total regular/larger 
LDL ratio
0.7 (0.7–0.8) 0.8 (0.8–1.1) 0.03*
All sphingolipid data were expressed relative to the cholesterol concentration 
in total plasma or the respective LDL peak. Data are presented as median (range) 
of the area under the curve. LDL indicates low-density lipoprotein.
*Significant values.
Table 4. Sphingomyelin Content of regular and larger LDL
Advanced- 
Diseased Pigs
Mildly  
Diseased Pigs P Value
SM(d18:1/16:0) total 
plasma (×10−3)
17.0 (8.0–17.4) 13.4 (11.4–22.6) 0.55
SM(d18:1/16:0) regular 
LDL (×10−3)
26.1 (21.4–28.6) 24.0 (20.2–26.4) 0.42
SM(d18:1/16:0) larger 
LDL (×10−3)
36.9 (34.9–41.6) 25.8 (22.3–35.1) 0.032*
SM(d18:1/16:0) regular/
larger LDL
0.7 (0.6–0.7) 0.8 (0.8–1.1) 0.008*
SM(d18:1/18:0) total 
plasma (×10−3)
2.9 (1.2–3.0) 2.6 (1.7–3.9) 0.55
SM(d18:1/18:0) regular 
LDL (×10−3)
4.1 (2.8–5.4) 3.3 (2.9–4.0) 0.31
SM(d18:1/18:0) larger 
LDL (×10−3)
5.5 (4.5–7.0) 4.3 (3.0–5.1) 0.032*
SM(d18:1/18:0) regular/
larger LDL ratio
0.7 (0.6–0.8) 0.8 (0.7–1.1) 0.008*
SM(d18:1/18:1) total 
plasma (×10−3)
0.6 (0.3–0.7) 0.4 (0.3–0.9) 0.55
SM(d18:1/18:1) regular 
LDL (×10−3)
0.7 (0.5–0.9) 0.6 (0.4–0.8) 0.22
SM(d18:1/18:1) larger 
LDL (×10−3)
1.0 (0.9–1.2) 0.7 (0.5–1.0) 0.10
SM(d18:1/18:1) regular/
larger LDL ratio
0.8 (0.5–0.8) 0.8 (0.7–1.1) 0.31
SM(d18:1/20:0) total 
plasma (×10−3)
3.9 (1.5–4.2) 4.3 (2.6–5.7) 0.31
SM(d18:1/20:0) regular 
LDL (×10−3)
3.5 (2.5–4.0) 3.3 (2.5–4.5) 0.84
SM(d18:1/20:0) larger 
LDL (×10−3)
5.0 (4.4–5.7) 4.5 (3.0–5.5) 0.31
SM(d18:1/20:0) regular/
larger LDL ratio
0.7 (0.6–0.8) 0.8 (0.7–1.1) 0.06
SM(d18:1/22:0) total 
plasma (×10−3)
6.3 (4.4–7.5) 6.4 (5.0–9.0) 0.55
SM(d18:1/22:0) regular 
LDL (×10−3)
4.3 (4.0–5.2) 4.6 (3.7–4.8) 1.0
SM(d18:1/22:0) larger 
LDL (×10−3)
5.3 (4.8–7.6) 5.6 (4.2–6.4) 0.55
SM(d18:1/22:0) regular/
larger LDL ratio
0.8 (0.7–0.8) 0.8 (0.8–1.1) 0.31
SM(d18:1/24:0) total 
plasma (×10−3)
3.3 (2.7–4.7) 3.7 (2.8–4.9) 0.31
SM(d18:1/24:0) regular 
LDL (×10−3)
2.1 (1.4–2.4) 1.6 (1.1–2.0) 0.22
SM(d18:1/24:0) larger 
LDL (×10−3)
2.5 (1.8–2.8) 2.0 (1.5–2.7) 0.31
SM(d18:1/24:0) regular/
larger LDL ratio
0.8 (0.8–0.9) 0.8 (0.6–1.0) 0.84
SM(d18:1/24:1) total 
plasma (×10−3)
14.6 (13.6–20.1) 16.5 (12.3–21.4) 0.69
SM(d18:1/24:1) regular 
LDL (×10-3)
10.7 (8.5–14.8) 10.2 (7.1–11.0) 0.31
SM(d18:1/24:1) larger 
LDL (×10−3)
12.9 (11.4–17.0) 12.1 (9.4–14.4) 0.55
SM(d18:1/24:1) regular/
larger LDL ratio
0.7 (0.7–0.9) 0.8 (0.7–1.0) 1.0
Table 4. Continued
Advanced- 
Diseased Pigs
Mildly  
Diseased Pigs P Value
(Continued )
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Different from other studies that describe the occurrence 
of triglyceride-rich larger LDL (ie, IDL), the larger LDL 
particles we observed were similar in size to VLDL. We 
still considered these particles to be LDL because of the 
very low triglyceride levels after size separation and the 
very low levels of VLDL-C after density gradient ultra-
centrifugation. Lipoproteins with the density of LDL, with 
the size of VLDL and with low triglyceride levels have 
been observed before in atherosclerotic tissue homog-
enates41 and in plasma of atherogenic diet-fed pigs with 
an LDLR-mutation15 (same breed used in this study) and 
with an PCSK9-mutation.17 However, this larger LDL has 
not been linked to disease severity before.
Besides cholesterol, also the distribution of sphingolip-
ids over larger and regular LDL was significantly different 
between AD and MD pigs at T1 which could indicate a 
difference in LDL functionality. For S1P, the regular/larger 
LDL ratio was higher in ADs than in MDs. Furthermore, 
both the long-chain ceramide and long-chain SM content 
were relatively higher in larger LDL of the ADs compared 
Figure 4. Low-density lipoprotein (LDL) profiles of 3 patients with homozygous familial hypercholesterolemia (FH).  
Lipoproteins were separated on density using density-gradient ultracentrifuge (DGUC). Subsequently, the pooled LDL fractions were subjected 
to fast-protein liquid chromatography (FPLC) revealing the presence of regular LDL and larger LDL in patients with homozygous FH. HDL 
indicates high-density lipoprotein; and VLDL, very-low–density lipoproteins.
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with the MDs. Sphingolipids, like SMs, S1P and ceramides, 
are a large group of structurally and functionally diverse 
lipids that are found in lipoproteins where they preserve 
structure and play a role in functionality of the lipoproteins. 
In vitro studies have shown that SM contained in LDL 
can undergo hydrolysis by sphingomyelinases, leading to 
increased LDL-ceramide levels, which in turn promotes 
LDL aggregation42–44 and fusion.44 Aggregated/fused 
LDL can infiltrate into the vessel wall via enhanced binding 
to proteoglycans.43,44 Accordingly, LDL in atherosclerotic 
plaques contains markedly higher levels of ceramide com-
pared with LDL in plasma or in the healthy vessel wall.43,45 
High levels of LDL-derived ceramides and SMs in the ves-
sel wall can induce apoptosis,46 foam cell formation42,43 or 
increase plaque inflammation.47 Higher LDL-ceramide and 
SM levels at T1 may thus contribute to the enhanced ath-
erosclerosis development in AD pigs.
The larger LDL observed in our FH pigs may con-
sist of aggregated LDL as Oörni et al44 showed that 
the aggregation/fusion of ceramide-rich LDL can give 
rise to 2 LDL subclasses upon separation by size-exclu-
sion. This hypothesis is in line with the high SM levels 
observed in regular LDL of the ADs, which could make 
this LDL subtype more prone to aggregation. However, 
MD pigs presented with the highest larger LDL-C levels 
which contained relatively low ceramide levels, rendering 
aggregation unlikely.
The larger LDL of the AD and MD pigs differs in long-
chain, but not in very long-chain ceramides, suggesting 
that besides ceramide concentration, also ceramide chain-
length influences the atherogenicity. This hypothesis is 
strengthened by an observation by Hartmann et al48 who 
reported that an increase in long-chain over very-long-chain 
ceramides can enhance cell proliferation and apoptosis.
The fact that we only observed the clear differences 
in cholesterol and sphingolipid distribution over the 2 
LDL subtypes early after the start of the atherogenic diet 
could indicate a possible metabolic or genetic adjust-
ment to the diet as, for example, observed by Kleeman et 
al.49 However, the large differences in LDL profile pres-
ent early in the study not only indicate the possible use 
of this profile as an early biomarker, but might also point 
to a causal relationship with the sensitivity for initiation of 
coronary atherosclerosis development.
Since the 2 different LDL subtypes can only be identi-
fied using FPLC instead of by the more commonly applied 
DGUC technique, a recommendation for future studies 
would be to characterize the components of the lipopro-
tein fractions also after lipoprotein separation by FPLC.
Clinical Relevance
Multiple clinical studies associated plasma-levels of 
ceramides and SMs with CAD development,50 vul-
nerable plaque composition,51 and with future major 
adverse cardiovascular events.26,51,52 Furthermore, 
higher ratios of Cer(d18:1/16:0)/Cer(d18:1/24:0) and 
Cer(d18:1/18:0)/Cer(d18:1/24:0) have been pinpointed 
as predictors for cardiovascular death.26,51 Based on the 
plasma levels of ceramides and SMs, we could not dis-
tinguish AD from MD pigs, possibly by a lack of power. 
When we, however, assessed the ceramide ratios in the 2 
LDL subclasses at T1, these were directly related to dis-
ease severity. These data suggest that assessment of the 
cholesterol and sphingolipid distribution over the 2 LDL 
subclasses is a highly potent and possibly even stronger 
early biomarker for individual risk assessment of coronary 
atherosclerosis development than LDL-C and sphingolipid 
levels in plasma. Future studies are necessary to further 
elucidate the exact composition and biological function of 
larger LDL, and of the importance of the regular-/larger 
LDL balance in atherosclerosis initiation and progression.
An interesting observation is the occurrence of the 
distinct LDL profile with regular and larger LDL in the 
plasma of 3 patients with homozygous FH in whom the 
LDL-C ratios displayed pronounced differences between 
the patients. Cardiovascular disease severity is highly 
variable in patients with FH and currently, no existing bio-
marker can reliably predict cardiovascular disease devel-
opment in individual patients with FH.53 The distinct LDL 
profile described in this study forms a promising early 
biomarker for individual patients with FH and even a 
potential drug target. A clinical study with a larger cohort 
of patients with homozygous and heterozygous FH, spe-
cifically also including women, will have to show the value 
of this LDL profile as a biomarker and as a risk factor for 
cardiovascular disease. It also needs to be determined 
whether this distinct LDL profile is also present in other 
patients with dyslipidemia and whether lipid-lowering 
medication like statins influences this LDL profile.
Limitations
The sample size in this study was relatively small. The divi-
sion of the group of pigs with regard to disease severity 
was unforeseen and resulted in a low number of animals 
with advanced disease, but it also enabled the discov-
ery of a new, high-potential biomarker for atherosclero-
sis development. Despite the low number of animals in 
both groups, this potential biomarker still came out as a 
strong, significant predictor. Furthermore, while histology 
was important for determining the plaque composition at a 
detailed level, the lack of perfusion fixation of the coronary 
histological samples hampered accurate quantification of 
plaque size. Besides, the low number of patients did not 
allow for a study to the relation with clinical outcome, but 
this first exploratory study did establish the first proof of 
the presence of a potential new biomarker for CAD.
Conclusions
The adult, homozygous FH FBM pig model is a large ani-
mal model in which half of the pigs allows for assessment 
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of early plaque development while the other half demon-
strates development of advanced coronary atherosclerotic 
plaques when fed an atherogenic diet. This latter group 
of ADs presented with widespread development of large, 
lumen intruding plaques with extensive unstable, human-
like features. These features render these pigs very suit-
able for testing and validating new interventions and 
(invasive) imaging techniques. Besides, we identified a 
distinct LDL profile in which a detailed component analy-
sis revealed that the distribution of cholesterol and sphin-
golipids over larger and regular LDL early after the start of 
the diet was directly associated with the severity of coro-
nary atherosclerosis development. Despite the low number 
of pigs, these measurements were highly significantly dif-
ferent between both groups of pigs, indicating the power 
and potential of this biomarker. Since this LDL profile was 
already present before the start of major plaque develop-
ment, there may be a causal relation with plaque initiation. 
This novel biomarker is highly useful to select ADs early in 
the study. Moreover, since we also detected this specific 
LDL profile in human homozygous patients with FH, this 
specific LDL profile might have potential to function as an 
early biomarker to indicate cardiovascular risk in individual 
(FH) patients, or to become a treatment target.
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